e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis
Tetiana Bondarenko (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Tetiana Bondarenko, Oleksandr Varunkiv
Source:
International Congress 2015 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster Session
Number:
3875
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tetiana Bondarenko (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Tetiana Bondarenko, Oleksandr Varunkiv. Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 3875
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
The dynamics of IV-type collagen contens in balf of patients with chronic bronchitis and chronic bronchitis complicated with secondary bronchiectasis
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
Source: Eur Respir J 2012; 39: 1354-1360
Year: 2012
Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006
Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology.
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 194s
Year: 2001
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
Clinical and temporal characteristics of chronic bronchitis complicated with secondary bronchiectasis
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Management of chronic airway infection in bronchiectasis
Source: Virtual Congress 2020 – The future of bronchiectasis management
Year: 2020
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept